Cargando…
Promoter hypomethylation of NY-ESO-1, association with clinicopathological features and PD-L1 expression in non-small cell lung cancer
Cancer-Testis antigens (CTA) are immunogenic molecules with normal tissue expression restricted to testes but with aberrant expression in up to 30% of non-small cell lung cancers (NSCLCs). Regulation of CTA expression is mediated in part through promoter DNA methylation. Recently, immunotherapy has...
Autores principales: | Chüeh, Anderly C., Liew, Mun-Sem, Russell, Prudence A., Walkiewicz, Marzena, Jayachandran, Aparna, Starmans, Maud H.W., Boutros, Paul C., Wright, Gavin, Barnett, Stephen A, Mariadason, John M., John, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650321/ https://www.ncbi.nlm.nih.gov/pubmed/29088766 http://dx.doi.org/10.18632/oncotarget.18198 |
Ejemplares similares
-
Transketolase-like 1 ectopic expression is associated with DNA hypomethylation and induces the Warburg effect in melanoma cells
por: Jayachandran, Aparna, et al.
Publicado: (2016) -
Clinicopathological assessment of cancer/testis antigens NY-ESO-1 and MAGE-A4 in osteosarcoma
por: Hashimoto, Kazuhiko, et al.
Publicado: (2022) -
NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives
por: Thomas, Remy, et al.
Publicado: (2018) -
Evaluation of Production Protocols for the Generation of NY-ESO-1-Specific T Cells
por: Gong, Wenjie, et al.
Publicado: (2021) -
Biomarkers and subtypes of cancer
por: Starmans, Maud H.W., et al.
Publicado: (2015)